A Multi-center Prospective Cohort Study Based on Peritoneal Dialysis Telemedicine-assisted Platform

NCT03571451 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 7000

Last updated 2023-10-25

No results posted yet for this study

Summary

Increasing the proportion of patients on peritoneal dialysis (PD) may relieve the financial burden caused by the growing number of patients with end-stage renal disease (ESRD). The investigators are developing a PD database in China using peritoneal dialysis telemedicine-assisted platform (PD TAP). The survival rate and technique survival rate of PD patients, as well as risk factors associated with survival and technique survival will be analyzed through PD TAP.

Conditions

  • Peritoneal Dialysis

Sponsors & Collaborators

  • The Second Hospital of Hebei Medical University

    collaborator OTHER
  • Army Medical University, China

    collaborator OTHER
  • The First Affiliated Hospital of Zhengzhou University

    collaborator OTHER
  • Hebei Medical University Third Hospital

    collaborator OTHER
  • Peking University Shenzhen Hospital

    collaborator OTHER
  • Handan Central Hospital

    collaborator OTHER
  • Beijing Haidian Hospital

    collaborator OTHER
  • People's Hospital of Qinghai Province

    collaborator UNKNOWN
  • Cangzhou Central Hospital

    collaborator OTHER
  • The Second Affiliated Hospital of Harbin Medical University

    collaborator OTHER
  • Shengjing Hospital

    collaborator OTHER
  • The Second Hospital of Anhui Medical University

    collaborator OTHER
  • Peking University People's Hospital

    collaborator OTHER
  • The First Affiliated Hospital of BaoTou Medical College

    collaborator OTHER
  • The People's Hospital of Chuxiong Yi Autonomous Prefecture

    collaborator UNKNOWN
  • Beijing miyun district hospital

    collaborator UNKNOWN
  • Second Hospital of Shanxi Medical University

    collaborator OTHER
  • People's Hospital of Gansu

    collaborator UNKNOWN
  • Pingdingshan first people's Hospital

    collaborator UNKNOWN
  • The first people's hospital of Xining

    collaborator UNKNOWN
  • The First Hospital of Jilin University

    collaborator OTHER
  • Cangzhou People's Hospital

    collaborator OTHER
  • Taiyuan central hospital

    collaborator UNKNOWN
  • People's hospital of Langfang

    collaborator UNKNOWN
  • China Rehabilitation Research Center

    collaborator OTHER_GOV
  • Dongzhimen Hospital, Beijing

    collaborator OTHER
  • Department of Epidemiology and Biostatistics, School of Public Health, Peking University

    collaborator UNKNOWN
  • Department of Statistics, Peking University First Hospital

    collaborator UNKNOWN
  • Peking University First Hospital

    lead OTHER

Eligibility

Min Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-01
Primary Completion
2025-12-01
Completion
2025-12-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03571451 on ClinicalTrials.gov